Attached files
| file | filename |
|---|---|
| EX-21 - EXHIBIT 21 - Accelerate Diagnostics, Inc | accelerate-12312015xexh21.htm |
| EX-31.1 - EXHIBIT 31.1 - Accelerate Diagnostics, Inc | accelerate-12312015xexh311.htm |
| EX-32 - EXHIBIT 32 - Accelerate Diagnostics, Inc | accelerate-12312015xexh32.htm |
| EX-31.2 - EXHIBIT 31.2 - Accelerate Diagnostics, Inc | accelerate-12312015xexh312.htm |
| 10-K - 10-K - Accelerate Diagnostics, Inc | axdx-123115x10k.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:
(1) | Registration Statement (Form S-8 No. 333-187439) pertaining to the Accelerate Diagnostics, Inc. 2012 Omnibus Equity Incentive Plan, |
(2) | Registration Statement (Form S-3 No. 333-192321) of Accelerate Diagnostics, Inc., and |
(3) | Registration Statement (Form S-8 No. 333-199992) pertaining to the Accelerate Diagnostics, Inc. 2012 Omnibus Equity Incentive Plan; |
of our reports dated March 9, 2016, with respect to the financial statements of Accelerate Diagnostics, Inc. and the effectiveness of internal control over financial reporting of Accelerate Diagnostics, Inc., included in this Annual Report (Form 10-K) of Accelerate Diagnostics, Inc. for the year ended December 31, 2015.
/s/ Ernst & Young LLP
Phoenix, Arizona
March 9, 2016